NTLA ▲ +0.2% - Intellia Therapeutics, Inc. $NTLA - Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million Intellia Therapeutics secured a non-dilutive debt facility of up to $400 million from OrbiMed, providing capital without requiring new share issuance. The modest 0.2% gain suggests the market had already anticipated financing news or is weighing the debt obligation against the benefit of avoiding dilution. 04-SEP-2026 08:50 AM ET